脑肿瘤分割(BraTS)挑战赛2023:聚焦儿科(CBTN-CONNECT-DIPGR-ASNR-MICCAI BraTS-PEDs)
The Brain Tumor Segmentation (BraTS) Challenge 2023: Focus on Pediatrics (CBTN-CONNECT-DIPGR-ASNR-MICCAI BraTS-PEDs)
AI总结:
本文介绍首个聚焦儿童脑肿瘤的BraTS-PEDs 2023挑战赛,旨在通过标准化评估指标基准测试儿科胶质瘤体积分割算法,以促进自动化分割技术发展,惠及临床试验和儿童患者护理。
摘要:
儿童中枢神经系统肿瘤是儿童癌症相关死亡的最常见原因。儿童高级别胶质瘤的五年生存率低于20%。由于这些肿瘤的罕见性,其诊断常常被延误,治疗主要基于历史治疗理念,临床试验需要多机构合作。MICCAI脑肿瘤分割(BraTS)挑战赛是一个具有里程碑意义的社区基准活动,拥有12年成功创建成人胶质瘤分割与分析资源的经验。本文介绍了CBTN-CONNECT-DIPGR-ASNR-MICCAI BraTS-PEDs 2023挑战赛,这是首个专注于儿童脑肿瘤的BraTS挑战赛,其数据来自多个致力于儿科神经肿瘤学和临床试验的国际联盟。BraTS-PEDs 2023挑战赛通过使用BraTS 2023系列挑战赛统一采用的标准化定量性能评估指标,专注于对儿科脑胶质瘤体积分割算法的开发进行基准测试。从BraTS-PEDs多参数结构磁共振成像(mpMRI)训练数据中获取知识的模型,将在独立的验证集和未见过的测试集(包含高级别儿科胶质瘤的mpMRI数据)上进行评估。CBTN-CONNECT-DIPGR-ASNR-MICCAI BraTS-PEDs 2023挑战赛汇集了临床医生和人工智能/影像科学家,以促进自动化分割技术的更快发展,这些技术可能惠及临床试验,并最终改善脑肿瘤儿童的护理。
英文摘要:
Pediatric tumors of the central nervous system are the most common cause of cancer-related death in children. The five-year survival rate for high-grade gliomas in children is less than 20\%. Due to their rarity, the diagnosis of these entities is often delayed, their treatment is mainly based on historic treatment concepts, and clinical trials require multi-institutional collaborations. The MICCAI Brain Tumor Segmentation (BraTS) Challenge is a landmark community benchmark event with a successful history of 12 years of resource creation for the segmentation and analysis of adult glioma. Here we present the CBTN-CONNECT-DIPGR-ASNR-MICCAI BraTS-PEDs 2023 challenge, which represents the first BraTS challenge focused on pediatric brain tumors with data acquired across multiple international consortia dedicated to pediatric neuro-oncology and clinical trials. The BraTS-PEDs 2023 challenge focuses on benchmarking the development of volumentric segmentation algorithms for pediatric brain glioma through standardized quantitative performance evaluation metrics utilized across the BraTS 2023 cluster of challenges. Models gaining knowledge from the BraTS-PEDs multi-parametric structural MRI (mpMRI) training data will be evaluated on separate validation and unseen test mpMRI dataof high-grade pediatric glioma. The CBTN-CONNECT-DIPGR-ASNR-MICCAI BraTS-PEDs 2023 challenge brings together clinicians and AI/imaging scientists to lead to faster development of automated segmentation techniques that could benefit clinical trials, and ultimately the care of children with brain tumors.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。